Cannabis Giant Curaleaf Expands In This European Country Via New Acquisition
Curaleaf International has acquired Can4Med, a pharmaceutical wholesaler specialising in cannabinoid medications, to expand its operations in Poland. The deal will also improve patient access to medical cannabis products across Europe. Poland's National Agricultural Support Center implemented rules last year that increased the THC level permitted in industrial hemp from 0.2% to 0.3%, facilitating a more streamlined permitting process for farmers and buyers. In August 2022, Curaleaf International registered its extract-based medicines in Poland through a partnership with local firm CanPoland. Last year, Poland saw a significant increase in the adoption of medical cannabis, with over 3,000 kg distributed. Curaleaf CEO Matt Darin called the acquisition a "significant step forward" for his company, as Poland's medical cannabis market expands rapidly.
